| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-08 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-08 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 5e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |